Expression of vascular endothelial growth factor and p53 protein in association with neovascularization in human malignant gliomas
- PMID: 10328546
- DOI: 10.1007/BF02478890
Expression of vascular endothelial growth factor and p53 protein in association with neovascularization in human malignant gliomas
Abstract
We examined the expression of vascular endothelial growth factor (VEGF) protein, p53 protein, and the MIB-1 index in 43 patients with malignant gliomas in relation to tumor vascularization by an immunohistochemical method. Factor VIII-related antibody was employed for the evaluation of the vascularity and endothelial proliferation. Of the 42 cases of malignant gliomas, 36 (86%) demonstrated immunoreactivity for VEGF in their tumor cells, whereas 22 (52%) had VEGF in their endothelial cells. There was a tendency for the vascularity to be correlated with the immunoreactivity for VEGF (coefficient, 0.340). In addition, a marked increase in endothelial proliferation was evident in cases showing moderate to strong positivity for VEGF as compared with the others. Immunoreactivity for VEGF was found mostly in the malignant gliomas without p53 overexpression and/or with p53 overexpression. However, statistical analysis revealed a correlation between the grade of p53 overexpression and the grade of VEGF expression (coefficient, 0.507), but not between the VEGF and MIB-1 index in our series. There was a tendency for the MIB-1 indices to increase in correlation with increasing vascularity.
Similar articles
-
Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms.Int J Cancer. 1994 Nov 15;59(4):520-9. doi: 10.1002/ijc.2910590415. Int J Cancer. 1994. PMID: 7525492
-
Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas.Histopathology. 2001 Oct;39(4):409-15. doi: 10.1046/j.1365-2559.2001.01230.x. Histopathology. 2001. PMID: 11683943
-
Angiogenesis of glioma: evaluation of ultrastructural characteristics of microvessels and tubular bodies (Weibel-Palade) in endothelial cells and immunohistochemical findings with VEGF and p53 protein.Med Mol Morphol. 2005 Mar;38(1):36-42. doi: 10.1007/s00795-004-0273-0. Med Mol Morphol. 2005. PMID: 16158178 Review.
-
Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.Cancer Res. 1999 Nov 1;59(21):5608-14. Cancer Res. 1999. PMID: 10554042
-
Angiogenesis in malignant gliomas.Glia. 1995 Nov;15(3):339-47. doi: 10.1002/glia.440150313. Glia. 1995. PMID: 8586468 Review.
Cited by
-
Temozolomide based treatment in glioblastoma: 6 vs. 12 months.Oncol Lett. 2024 Jul 2;28(3):418. doi: 10.3892/ol.2024.14551. eCollection 2024 Sep. Oncol Lett. 2024. PMID: 39006948 Free PMC article.
-
Prolonged temozolomide for treatment of glioblastoma: preliminary clinical results and prognostic value of p53 overexpression.J Neurooncol. 2012 Jan;106(1):127-33. doi: 10.1007/s11060-011-0643-0. Epub 2011 Jul 2. J Neurooncol. 2012. PMID: 21725801
-
Anatomical specificity of vascular endothelial growth factor expression in glioblastomas: a voxel-based mapping analysis.Neuroradiology. 2016 Jan;58(1):69-75. doi: 10.1007/s00234-015-1602-9. Epub 2015 Oct 9. Neuroradiology. 2016. PMID: 26453565
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous